Classical methods for the study of steroid metabolism, whether applied to natural or structurally modified compounds, present well-known difficulties in methodology and interpretation. Both the oral and intravenous routes of administration generate particular problems. The types of food material present in the digestive tract, as well as the types of bacteria, may have significant influences on comparisons between species with different eating habits. Solubility of the steroid in the contents of the digestive tract may have considerable effect on absorption, which is also influenced by the physical properties (e. g. particle size) of the administered material. Nonpolar compounds such as progesterone are more effectively absorbed when dissolved in an oily vehicle than when administered as tablets or powder. Giannina et al. (1967) found 1\p=n-\2% of the dose in lymph after oral administration of a suspension of quinestrol, in contrast to 16% when the material was given in oil + monoglyceride. Further, tablet administration or intravenous injection (van der Molen et al. 1969 ) resulted in urinary excretion of 55-65%, whereas ad¬ ministration in a gelatin capsule reduced this figure by three-fourths.
Intravenous administration, whether as a single pulse or as prolonged in¬ fusion, may be influenced by the capacity of adaptive enzyme systems to enter into the metabolism of the steroid under study. Oral vs. intravenous ad¬ ministration may produce significant differences in other aspects of steroid metabolism, as in the type of conjugation (e.g. 17/5-oestradiol (Kulkarni 1970a ). On the assumption of a 600 ml plasma volume, only 8 % of the radioactivity is found in the plasma after 15 min. The half-life of the plasma radioactivity (which is known to be a mixture of compounds) can be estimated as 110 min during the first 2 hours and 180 min during the period 2-8 hours. Calculations of half-life after isolation and measurement of free plasma ethinyloestradiol itself are in progress. Fig. 2 shows the disappearance rates for the three ethinyl oestrogens in baboons when tracer amounts (7.5-30 ßg) are administered intravenously to animals primed for 2 weeks with thera¬ peutic levels of the same materials. The rapid disappearance of EE-sulphate activity is surprising, since sulphates of natural steroids have longer half-lives than the free compounds. In addition, the peripheral sequestration and plasma disappearance of mestranol is clearly different from that of the other two compounds. Comparable studies in human females, also pretreated with the respective compounds (Fig. 3) , show the same order of plasma radioactivity concentrations; the disappearance of mestranol does not show quite as much flattening after 2 hours as was observed in baboons. The concentrations of total radioactivity in baboon and human plasma were comparable. The plasma volume in humans is estimated to be about three times that of the baboons used in this study, and the data in Fig. 3 have been normalized by this factor. Table 1 shows some preliminary results of fractionation of plasma radio¬ activity after intravenous injection of several ethinyl oestrogens in man and baboon. There is a marked similarity in the patterns. A somewhat higher level of free ethinyloestradiol is seen in the baboon. There are slight differences in the proportions and trends of the various types of radioactivity from ethinyloestradoil sulphate in the two species. With mestranol, the relative amount of free steroid declines much more rapidly in the baboon than in man; the pro¬ portion of glucuronide and sulphate appears to be higher in man at the outset, but the relative amounts increase more rapidly in the baboon, and approach the human level by 8 hours.
The route of excretion (i. e. urinary vs. faecal) of administered steroids is quite different in certain species (e. g. dogs and rodents) from man; non-human (Beer 8c Gallagher 1955; Fishman et al. 1969 ) 50-70% of administered oestrone or oestradiol is excreted in the urine in about 4 days, and 7-9 % appears in the faeces. In sub-human primates (Table 2) over 50 % appears in the urine, less than 5 % in the faeces. In our laboratory (Kulkarni 1970a ) the average cumulative excretion of radioactive metabolites of ethinyloestradiol in the baboon was about 80 % in 4 days (Fig. 4) . In studies in humans, the mean cumulative excretion was 46 % (Kulkarni Sc Goldzieher 1970a) . Others have found cumulative excretions ranging from 25 to 60% (Kamyab et al. 1969; Cargill et al. 1969; Abdel-Aziz Sc Williams 1970) .
These data further support the finding that mestranol metabolism is marked¬ ly slower than that of the natural oestrogens. We have found a 20 % excretion (Brown 1955 ) destroy 2-and 6-hydroxylated derivatives (Fishman 1963 (Cargill et al. 1969 ). Kulkarni (1970 ) noted that most of the urinary radioactivity from ethinyloestradiol was present as material more polar than the parent com¬ pound, suggesting the possibility of 2-and 6-hydroxylation. Since it has been shown that baboon peripheral tissue can methylate 2-hydroxyoestradiol (Axelrod 1965), it is possible that 2-methoxy derivatives of ethinyloestradiol may also be formed. Chromatographie evidence for the presence of 2-methoxyoestrone in rhesus urine has been presented by Laumas (1969 (Goldzieher 8c Axelrod 1969 ). This pathway is highly significant, yielding 5-20 % androsterone from the administered precursor. A vestige of this pathway was shown to persist in man (Plant et al. 1969; Reddy et al. 1971) . Similarly, pregnanediol has been detected in the urine of pregnant baboons (Merkatz Sc Beling 1969) but has thus far escaped detection during the luteal phase of the menstrual cycle (Goldzieher, unpublished results). The baboon does, however, appear to convert progesterone to both the 5a-and 5/3-pregnanediols, although the per cent conversion is low: about 13 % of injected radioactivity was excreted as pregnanediols, compared to 12% as androsterone (Goldzieher Sc Axelrod 1969) .
The chimpanzee, on the other hand, is quite remarkably similar to the human in its metabolism of progesterone and 17a-hydroxyprogesterone (Romanoff et al. 1963 (Romanoff et al. , , 1966 (Romanoff et al. , 1968 . The metabolite pattern and the preponderance of pregnanediol and pregnanetriol in this species compare extremely well with data found in man (Fukushima et al. 1961 (Fukushima et al. , 1963 ). Pituitary weights were also un¬ affected by prolonged administration of oestradiol dipropionate to adult male rhesus monkeys, but the gonadotrophic activity was markedly inhibited . This is in contrast to the pituitary enlargement observed in adult female rats (Holmes Se Mandi 1962 (Goisis 1964; Mosca 1965) .
Norethynodrel-mestranol (5.0 and 0.075 mg daily) administered to 4-5 month old female rhesus monkeys did not produce any inhibitory effects on the ovarian response to pregnant mare serum gonadotrophin Ovulation was produced in 4 of 11 adult female monkeys during the an¬ ovulatory summer period, by injection of 0.5 mg of progesterone daily for 3 to 6 days (Pfeiffer 1950) . None of the 50 control animals ovulated. On the other hand, 0.5-5.0 mg progesterone administered daily between days 9-18 of the cycle blocked the preovulatory rise in serum LH and subsequent ovula¬ tion in normally cycling rhesus monkeys (Spies Sc Niswender 1971) .
Progestational steroids vary in their effect on the response of prepuberal rhesus monkeys to exogenous gonadotrophins (Table 5) (Claassen et al. 1971) . This is similar to results reported for man (Bishop el al. 1962; Vokaer 8c Ferin 1961; Eskes et al. 1970 ). (Morris Sc van Wagenen 1966) . These steroids had no effect on abortion when administered on days 18-167 of pregnancy. Postcoital administration of stilboestrol ap¬ parently has the same effect in humans (Kuchera 1971 (Graham 1970) . Recent studies (Graham 1970) Gall et al. (1969) .
Mammary gland
The effect of various oestrogens and progestins on mammary tissue has been of interest for decades, in view of the possible relation of these compounds to mammary neoplasia. The earlier literature on the effects of oestrogens has been tabulated by Russfield (1966) . (Beck 8c Wells 1969) . Beck (1969) (Beck 1969 (Goldman et al. 1968; Costrini et al. 1969; Kalkhoff et al. 1970) .
In further studies, Beck (1970) 
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